Back to top
more

Fidelity Select Pharmaceuticals: (MF: FPHAX)

(NASDAQ Mutual Funds) As of Feb 27, 2026 05:27 PM ET

$33.29 USD

+0.51 (1.56%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jan 31, 2026

Total Return %* Percentile Rank Objective
YTD 2.20 1
3 months 10.75 3
6 months 36.58 10
1 Year 28.44 14
3 Year 17.88 5
5 Year 12.14 1
10 Year 10.73 30

* Annual for three years and beyond.

Zacks Premium Research for FPHAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 41.54
% Yield NA
% SEC Yield NA
Net Assets (Mil $) 1/31/2026 1,430.54
% Turnover 1/31/2026 51.00

Risk

3 Year 5 Year 10 Year
Beta 0.69 0.57 0.63
Alpha 2.72 2.78 0.72
R Squared 0.22 0.29 0.39
Std. Dev. 17.16 15.79 15.03
Sharpe 0.83 0.63 2.00

Sector / Country Weightings

As of 1/31/2026 % of Portfolio
Health 78.55
Other 10.87
Services 5.78
Industrial Cyclical 2.97
Finance 1.66
Retail Trade 0.17

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2025)
% of Portfolio Value (Mil$)
ELI LILLY & CO 24.70 331.78
ASTRAZENECA PLC ADR 11.18 150.16
TOTAL*MONEY MARKET 6.41 86.13
JOHNSON & JOHNSON 5.42 72.77
MERCK & CO INC 5.03 67.57
GSK PLC ADR 4.88 65.60
UCB SA 4.83 64.91
GILEAD SCIENCES INC 4.83 64.86
ELANCO ANIMAL HEALTH INC 4.44 59.69

Stock Holding % of Net Assets

As Of 11/30/2025
Total Issues 48
Avg. P/E 25.77
Avg. P/Book 7.72
Avg. EPS Growth 14.65
Avg. Market Value (Mil $) 406,697

Composition

% of Portfolio
Stocks 93.85
Foreign Stocks 28.44
Cash 6.41
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.76
Other -1.02
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA